A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD
NCT07239765 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 67
Last updated 2025-11-20
Summary
Amphotericin B Cholesteryl Sulfate Complex (ABCD) is a generic drug of amphotericin B colloidal dispersion. This study aimed to explore the safety and efficacy of ABCD in patients with invasive mold disease.
Conditions
- Invasive Mold Disease
Interventions
- DRUG
-
ABCD
intravenous infusion
Sponsors & Collaborators
-
CSPC Ouyi Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-09
- Primary Completion
- 2024-04-08
- Completion
- 2024-04-29
Countries
- China
Study Locations
More Related Trials
-
Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis
NCT05471063 ·Status: UNKNOWN ·Phase: NA
-
Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
NCT07191756 ·Status: ACTIVE_NOT_RECRUITING
-
Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex
NCT01656382 ·Status: WITHDRAWN ·Phase: PHASE4
-
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
NCT00076869 ·Status: COMPLETED ·Phase: PHASE2
-
L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis
NCT06640296 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410 ·Status: RECRUITING
-
A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
NCT00037206 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
NCT00750737 ·Status: COMPLETED ·Phase: PHASE3
-
Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
NCT00003315 ·Status: COMPLETED ·Phase: PHASE3
-
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
NCT00986713 ·Status: UNKNOWN ·Phase: PHASE4
-
Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
NCT00761267 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
NCT00250432 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction
NCT07337720 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
NCT00177684 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
NCT00002019 ·Status: COMPLETED ·Phase: NA
-
Amphotericin Versus Posaconazole for Pulmonary Mucormycosis
NCT05468372 ·Status: COMPLETED ·Phase: PHASE2
-
Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
NCT02283905 ·Status: TERMINATED ·Phase: PHASE4
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
Cost-Effectiveness of Amphotericin B
NCT02527928 ·Status: UNKNOWN
-
Empirical Versus Preemptive Antifungal Therapy
NCT01288378 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
NCT00047827 ·Status: TERMINATED ·Phase: PHASE2
-
Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment
NCT00158730 ·Status: COMPLETED ·Phase: PHASE3
-
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179 ·Status: COMPLETED ·Phase: PHASE2